Case Report: Immune dysregulation associated with long-lasting regression of a (pre)leukemic clone

Publication date

2023-10-16

Authors

Koedijk, Joost B
van Beek, Thomas B
Vermeulen, Marijn A
Kester, Lennart A
Schweighart, Elizabeth K
Nierkens, StefanORCID 0000-0003-3406-817XISNI 0000000395421272
Belderbos, Mirjam E.ISNI 0000000389485413
Zwaan, C. Michel
Heitink-Pollé, Katja M J
Heidenreich, Olaf

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

cc_by

Abstract

Regression of leukemia in the absence of disease-modifying therapy remains poorly understood, although immunological mechanisms are thought to play a role. Here, we present a unique case of a 17-year-old boy with immune dysregulation and long-lasting regression of a (pre)leukemic clone in the absence of disease-modifying therapy. Using molecular and immunological analyses, we identified bone marrow features associated with disease control and loss thereof. In addition, our case reveals that detection of certain fusion genes with hardly any blasts in the bone marrow may be indicative of an accompanying oncogenic fusion gene, with implications for disease surveillance- and management in future patients.

Keywords

Adolescent, Bone Marrow, Clone Cells, Humans, Leukemia, Male, acute myeloid leukemia, childhood, immune-mediated, spontaneous remission, case report, Immunology and Allergy, Immunology, Case Reports, Research Support, Non-U.S. Gov't

Citation

Koedijk, J B, van Beek, T B, Vermeulen, M A, Kester, L A, Schweighart, E K, Nierkens, S, Belderbos, M E, Zwaan, C M, Heitink-Pollé, K M J & Heidenreich, O 2023, 'Case Report : Immune dysregulation associated with long-lasting regression of a (pre)leukemic clone', Frontiers in Immunology, vol. 14, 1280885, pp. 1-6. https://doi.org/10.3389/fimmu.2023.1280885